Orbimed Advisors LLC Vaxcyte, Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 387,000 shares of PCVX stock, worth $33.3 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

387,000

Previous 795,900 51.38%

Holding current value

$33.3 Million

Previous $60.1 Million 26.48%

% of portfolio

1.04%

Previous 1.45%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.52 - $117.12 $28.8 Million - $47.9 Million	-408,900 Reduced 51.38%	387,000 $44.2 Million
Q2 2024 Aug 14, 2024	SELL	$60.06 - $78.77 $16.2 Million - $21.3 Million	-270,231 Reduced 25.35%	795,900 $60.1 Million
Q1 2024 May 15, 2024	SELL	$59.79 - $81.05 $5.2 Million - $7.05 Million	-86,960 Reduced 7.54%	1,066,131 $72.8 Million
Q4 2023 Feb 14, 2024	BUY	$45.35 - $63.41 $6.62 Million - $9.25 Million	145,943 Added 14.49%	1,153,091 $72.4 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $9.63 Million - $15 Million	277,709 Added 38.07%	1,007,148 $50.3 Million
Q1 2023 May 15, 2023	SELL	$36.27 - $47.2 $20.1 Million - $26.1 Million	-553,687 Reduced 43.15%	729,439 $27.3 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $11.6 Million - $27.1 Million	565,226 Added 78.73%	1,283,126 $61.5 Million
Q3 2022 Nov 14, 2022	SELL	$21.69 - $28.53 $17.3 Million - $22.7 Million	-795,759 Reduced 52.57%	717,900 $17.2 Million
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $7.28 Million - $11 Million	416,959 Added 38.02%	1,513,659 $36.6 Million
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $1.2 Million - $1.64 Million	62,035 Added 6.0%	1,096,700 $26.1 Million
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $1.81 Million - $2.41 Million	89,265 Added 9.44%	1,034,665 $26.2 Million
Q2 2021 Aug 16, 2021	BUY	$16.45 - $24.06 $4.88 Million - $7.14 Million	296,626 Added 45.72%	945,400 $21.3 Million
Q1 2021 May 17, 2021	BUY	$18.66 - $29.16 $345,471 - $539,868	18,514 Added 2.94%	648,774 $12.8 Million
Q4 2020 Feb 16, 2021	SELL	$26.57 - $51.74 $278,985 - $543,270	-10,500 Reduced 1.64%	630,260 $16.7 Million
Q3 2020 Nov 16, 2020	SELL	$26.5 - $55.4 $5.54 Million - $11.6 Million	-209,240 Reduced 24.62%	640,760 $31.6 Million
Q2 2020 Aug 14, 2020	BUY	$26.15 - $35.45 $22.2 Million - $30.1 Million	850,000 New	850,000 $26.9 Million

Others Institutions Holding PCVX

# of Institutions

352

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.1B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Vaxcyte, Inc. Transaction History